Federal Register / Vol. 87, No. 101 / Wednesday, May 25, 2022 / Notices 31909 

approved finished dosage forms for 

commercial sale. 

Kristi N. O’Malley, 

Assistant Administrator. 

[FR Doc. 2022–11266 Filed 5–24–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1004] 

Bulk Manufacturer of Controlled 

Substances Application: Scottsdale 

Research Institute 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Scottsdale Research Institute, 

has applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTARY INFORMATION listed 

below for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before July 25, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

July 25, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on March 28, 2022, 

Scottsdale Research Institute, 12815 

North Cave Creek Road, Phoenix, 

Arizona 85022, applied to be registered 

as a bulk manufacturer of the following 

basic class(es) of controlled 

substance(s): 

Controlled 

substance 

Drug 

code Schedule 

Lysergic Acid 

Diethylamide.

7315 I 

The company plans to bulk 

manufacture the listed controlled 

substance for internal testing to prepare 

a drug master file. No other activities for 

these drug codes are authorized for this 

registration. 

Kristi N. O’Malley, 

Assistant Administrator. 

[FR Doc. 2022–11255 Filed 5–24–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1011] 

Bulk Manufacturer of Controlled 

Substances Application: Royal 

Emerald Pharmaceuticals 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Royal Emerald 

Pharmaceuticals has applied to be 

registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to Supplementary 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before July 25, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

July 25, 2022. 

ADDRESSES: The Drug Enforcement 

Administration (DEA) requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on March 25, 2022, Royal 

Emerald Pharmaceuticals, 14011 Palm 

Drive, Desert Hot Springs, California 

92240–6845, applied to be registered as 

a bulk manufacturer of the following 

basic class(es) of controlled 

substance(s): 

Controlled 

substance 

Drug 

code Schedule 

Marihuana Extract ........... 7350 I 

Marihuana ........................ 7360 I 

Tetrahydrocannabinols .... 7370 I 

The company plans to bulk 

manufacture the listed controlled 

substances to provide Marihuana 

(Cannabis) as botanical raw material 

and/or active pharmaceutical 

ingredients (API) to DEA research 

registrants and manufacturers. No other 

activities for these drug codes are 

authorized for this registration. 

Kristi N. O’Malley, 

Assistant Administrator. 

[FR Doc. 2022–11257 Filed 5–24–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1015] 

Importer of Controlled Substances 

Application: United States 

Pharmacopeial Convention 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: United States Pharmacopeial 

has applied to be registered as an 

importer of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before June 24, 2022. Such 

persons may also file a written request 

for a hearing on the application on or 

before June 24, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 


lotter on DSK11XQN23PROD with NOTICES1

I I 

I I